Neogenomics Inc
NEO
ISIN null / Valor 1589606
Neogenomics Inc
UMushroom community rating:
About company
NeoGenomics Inc is a specialized laboratory and diagnostics company with a primary focus on cancer-related services. For over 18 years, it has been at the forefront of providing comprehensive testing and analysis for cancer diagnostics and clinical trials. The company operates on a global scale, employing a diverse team of professionals including physicians, scientists, and laboratory experts. These professionals collaborate closely with cancer care teams to offer critical oncological insights, aiming to significantly improve patient outcomes. NeoGenomics positions itself as a key player in the oncology sector by offering a range of services tailored to meet the needs of oncologists, pathologists, pharmaceutical companies, and academic institutions. Its offerings encompass diagnostic services, pharmaceutical services, and information services, all designed to facilitate the advancement of cancer care and treatment. Through its dedication to innovation and patient care, NeoGenomics strives to contribute to the development of new and improved cancer therapies, thereby enhancing the quality of life for those affected by cancer.
Summarized from source with an LLMView SourceSector: FinanceKey figures
Performance
Volatility
1635 M
Market cap (USD)
1,486,186
Daily traded volume (Shares)
16.95 / 16.39
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
